Filing Flows › Senti Biosciences Holdings (SNTI) › Who owns the stock
Who owns Senti Biosciences Holdings (SNTI) stock
18 funds reported Senti Biosciences Holdings (SNTI) shares in their latest 13F filings, worth $2.2M in all. The largest holder is Nantahala Capital Management, LLC ($977K). Last quarter 6 funds added to their stakes and 0 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 888,000 | $977K | new | 2026-06-30 |
| Vanguard Capital Management LLC | 537,504 | $591K | new | 2026-06-30 |
| Geode Capital Management, LLC | 187,065 | $206K | new | 2026-06-30 |
| Citadel Advisors LLC | 107,100 | $118K | new | 2026-06-30 |
| Vanguard Fiduciary Trust | 91,193 | $100K | new | 2026-06-30 |
| Jane Street Group, LLC | 52,530 | $58K | new | 2026-06-30 |
| Menlo Ventures Management, L.P. | 35,737 | $39K | new | 2026-06-30 |
| Northern Trust | 32,154 | $35K | new | 2026-06-30 |
| XTX Topco | 23,610 | $26K | new | 2026-06-30 |
| Virtu Financial LLC | 22,795 | $25K | new | 2026-06-30 |
| UBS Group AG | 14,432 | $16K | new | 2026-06-30 |
| State Street | 10,010 | $11K | new | 2026-06-30 |
| Tower Research Capital LLC | 7,344 | $8K | new | 2026-06-30 |
| BlackRock | 4,004 | $4K | new | 2026-06-30 |
| Royal Bank of Canada | 4,015 | $4K | new | 2026-06-30 |
Senti Biosciences Holdings' latest quarter
Senti Biosciences Holdings, Q2 2026: revenue $17K, net loss $12.8M, operating cash flow −$14.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most SNTI stock?
By the latest 13F filings: Nantahala Capital Management, LLC ($977K); Vanguard Capital Management LLC ($591K); Geode Capital Management, LLC ($206K); Citadel Advisors LLC ($118K); Vanguard Fiduciary Trust ($100K).
What is the short interest in SNTI?
427,404 shares were sold short at the 2026-10-15 settlement, -12.27% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.